On December 27, 2023, the National Administration of Disease Prevention and Control issued the industry standard Configuration and Management of Laboratory Instruments and Equipment for Disease Prevention and Control Institutions. This standard specifies the main instruments and equipment and their required quantities for provincial, municipal, and county-level CDCs. Notably, the fully automatic microbial nucleic acid detection system has been included in the standard, requiring deployment by all CDCs.

Rocgene

iFIND® Fully Automatic Nucleic Acid Detection and Analysis System

Based on microfluidic technology, the iFIND® Fully Automatic Nucleic Acid Detection and Analysis System uses integrated closed cartridges with pre‑loaded lyophilized reagents. It overcomes the limitations of traditional molecular detection laboratories, including strict environmental requirements, dependence on multiple supporting devices, and high demand for skilled personnel. It eliminates the drawbacks of conventional nucleic acid testing: complex workflows, cumbersome operation, time and labor consumption, and stringent environmental conditions, truly realizing fully automatic “sample-in, result-out” nucleic acid detection.

Technical Features

Application Scenarios

The supporting detection kits for iFIND® cover multiplex and ultra‑multiplex nucleic acid detection for pathogens including tuberculosis identification and drug resistance, fungi, bacteria, and multidrug‑resistant bacteria. The iFIND® system adopts a modular design, in which each module operates independently without interference. Different types of nucleic acid detection assays can run simultaneously, allowing random access testing for various samples. With reasonable running costs, compact size, and flexible throughput, it is highly suitable for CDC applications such as responses to major public health emergencies and rapid outbreak detection.

Application Fields